Resumen Fundamento: La coexistencia de trastornos de la conducta alimentaria (TCA) y del trastorno por déficit de atención e hiperactividad (TDAH) es frecuente. El objetivo del estudio fue cuantificar la presencia de sintomatología TDAH en pacientes adultos con TCA y evaluar posibles correlaciones entre ambas sintomatologías. Material y métodos: Estudio transversal en pacientes con TCA. Se cumplimentaron los cuestionarios Eating Attitudes Test de 40 ítems (EAT-40), Eating Disorder Inventory 3ª edición (EDI-3) y la versión abreviada del Adult ADHD Self-Report Scale (ASRS v1.1). Aquellos pacientes con ≥12 puntos en ASRS v1.1 completaron el cuestionario Attention Déficit Hyperactivity Disorder Rating Scale 4ª edición (ADHD-RS IV). Resultados: El 42,6% de los 108 pacientes incluidos puntuaron ≥12 en el ASRS v1.1. Estos sujetos puntuaron más en bulimia y en algunas escalas de desajuste psicológico del EDI-3, y aquellos con conductas de atracón y/o purga puntuaron más en Trastornos psicobiológicos del EAT-40 y en Insatisfacción corporal y Riesgo de TCA del EDI-3. No hubo diferencias en ADHD-RS IV según fueran cuadros restrictivos puros (n=13) o compulsivo-purgativos (n=33). La sintomatología TDAH correlacionó más con la clínica alimentaria y con el desajuste psicológico general en los casos compulsivo-purgativos. Conclusiones: En población clínica con TCA son frecuentes los síntomas sugestivos de TDAH, más en cuadros con clínica compulsivo-purgativa pero no necesariamente más intensos. La correlación entre TDAH y TCA es mayor en cuadros compulsivo-purgativos. Los síntomas de TDAH conllevan mayor desajuste psicológico y mayor gravedad a nivel alimentario en los cuadros con sintomatología compulsivo-purgativa.
No negative attitude towards the mentally ill was perceived. PC health staff perceived their lack of psychiatric knowledge and that they did not have sufficient dealings with the MHC, and showed good predisposition towards improving both questions.
Introduction: The concept of catatonia has undergone a major evolution from the first descriptions by Kahlbaum catatonic syndrome. Although Kraepelin and Bleuler as mostly related to the dementia praecox and schizophrenia, respectively, it was later shown that its incidence is higher in affective disorders and especially mania. In 2003 Taylor and Fink reviews the diagnostic criteria and warn of its underdiagnosis Methods: From the presentation of a case, we conducted a systematic review in various databases (PubMed, Medline…) Results: A case report. We present the case of a 46 year old woman diagnosed with bipolar disorder type I. First depressive episode at age 16. In the past 3 years has presented two hypomanic, a mixed episode and a depressive episode. The days before admission, presented disorganized behavior, confusion, bewilderment, motor retardation, respond poorly to stimuli, partially mute. Coincides with the abandonment of regular medication. Psychomotor agitation presented at admission. Lorazepam treatment was started 15 mg, Olanzapine 5 mg, venlafaxine 150 mg and 200 mg lamotrigine. After two weeks of income stabilization was achieved psychopathology. Conclusions: The presentations of this syndrome are varied, being able to alternate states of inhibition and agitation. Catatonia inhibited or benign catatonia, is the most common presentation. Malignant catatonia is characterized by acute onset, high-impact organic. The etiology can be multiple: psychiatric illness, medical conditions, pharmacological and toxic. Treatment should be hospitable. Initially with benzodiazepines (lorazepam, diazepam). If no response or the organic state is committed we recommend the use of electroconvulsive therapy.
Introduction: Anabolic steroids are synthetic derivatives of testosterone that are widely used both for sport and to achieve an athletic body image. Its use has increased greatly in recent years. The abuse is associated with side effects both physically (endocrine, cardiovascular, liver ...) and psychological (anxiety disorders, depression, psychosis, aggression, suicide), in some cases severe and irreversible. Many sports supplements are contaminated with these substances. Methods: Based on the exposure of a clinical case, we conducted a systematic review in various databases. Results and case report: 25 year old male with no personal or family psychiatric history. It has no history of drug toxicity. Coinciding with a period of major stress (working as a private escort and simultaneously preparing exams for police) he started intensive physical training and sports supplements diet (including anabolic steroids). The patient gradually begins to appear nervous, irritable and sleep disturbance. Acutely presents a picture of delusions of prejudice, self-referentiality and elevated distress so he needed an urgent psychiatric income. Was treated with risperidone 4 mg / day and lorazepam 5 mg / day. Psychotic symptoms disappeared within two days. During outpatient follow-up medication was gradually reduced. The evolution has been favorable getting a full recovery in few weeks. Conclusions: The steroid-induced psychotic episodes are rare, mainly consisting of paranoid delusions or grandeur, usually in the context of a manic episode. In most reported cases, the psychotic symptoms disappear quickly, within several weeks after discontinuation of the offending substance. Occasionally required a brief treatment with antipsychotics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.